Plexus Corp. (NASDAQ:PLXS – Free Report) – Equities researchers at Zacks Research reduced their Q3 2025 earnings per share estimates for Plexus in a note issued to investors on Wednesday, May 7th. Zacks Research analyst V. Doshi now expects that the technology company will earn $1.48 per share for the quarter, down from their previous forecast of $1.49. The consensus estimate for Plexus’ current full-year earnings is $5.90 per share. Zacks Research also issued estimates for Plexus’ Q4 2025 earnings at $1.57 EPS, FY2025 earnings at $5.93 EPS, Q1 2026 earnings at $1.60 EPS, Q2 2026 earnings at $1.50 EPS, Q3 2026 earnings at $1.66 EPS, FY2026 earnings at $6.49 EPS, Q1 2027 earnings at $1.74 EPS, Q2 2027 earnings at $1.55 EPS and FY2027 earnings at $7.21 EPS.
A number of other equities analysts have also weighed in on PLXS. Stifel Nicolaus set a $145.00 target price on Plexus in a research note on Thursday, April 24th. Benchmark lowered their target price on Plexus from $170.00 to $160.00 and set a “buy” rating on the stock in a research note on Friday, April 25th. Finally, Needham & Company LLC reiterated a “buy” rating and set a $162.00 target price (down previously from $172.00) on shares of Plexus in a research note on Friday, April 25th. Two equities research analysts have rated the stock with a hold rating and three have issued a buy rating to the company’s stock. Based on data from MarketBeat, the stock has an average rating of “Moderate Buy” and an average price target of $155.67.
Plexus Price Performance
NASDAQ:PLXS opened at $133.35 on Monday. The company has a quick ratio of 0.70, a current ratio of 1.53 and a debt-to-equity ratio of 0.07. The stock’s 50 day moving average price is $124.29 and its two-hundred day moving average price is $143.28. The firm has a market capitalization of $3.61 billion, a price-to-earnings ratio of 30.94 and a beta of 0.80. Plexus has a 12-month low of $100.96 and a 12-month high of $172.89.
Plexus (NASDAQ:PLXS – Get Free Report) last released its quarterly earnings data on Wednesday, April 23rd. The technology company reported $1.66 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.54 by $0.12. The firm had revenue of $980.17 million for the quarter, compared to analyst estimates of $980.07 million. Plexus had a return on equity of 10.36% and a net margin of 3.03%. The business’s revenue for the quarter was up 1.4% compared to the same quarter last year. During the same quarter in the prior year, the company earned $0.94 earnings per share.
Institutional Investors Weigh In On Plexus
A number of large investors have recently modified their holdings of PLXS. Barclays PLC boosted its holdings in shares of Plexus by 139.4% in the 3rd quarter. Barclays PLC now owns 48,786 shares of the technology company’s stock valued at $6,669,000 after purchasing an additional 28,406 shares in the last quarter. Wealth Enhancement Advisory Services LLC boosted its holdings in shares of Plexus by 17.2% in the 4th quarter. Wealth Enhancement Advisory Services LLC now owns 1,779 shares of the technology company’s stock valued at $278,000 after purchasing an additional 261 shares in the last quarter. USA Financial Formulas acquired a new stake in shares of Plexus in the 4th quarter valued at $56,000. Hennion & Walsh Asset Management Inc. boosted its holdings in shares of Plexus by 59.0% in the 4th quarter. Hennion & Walsh Asset Management Inc. now owns 3,445 shares of the technology company’s stock valued at $539,000 after purchasing an additional 1,278 shares in the last quarter. Finally, Blue Trust Inc. boosted its holdings in shares of Plexus by 12.1% in the 4th quarter. Blue Trust Inc. now owns 776 shares of the technology company’s stock valued at $121,000 after purchasing an additional 84 shares in the last quarter. Institutional investors and hedge funds own 94.45% of the company’s stock.
Insider Transactions at Plexus
In other Plexus news, insider Michael J. Running sold 1,250 shares of the firm’s stock in a transaction on Friday, February 21st. The stock was sold at an average price of $138.62, for a total transaction of $173,275.00. Following the transaction, the insider now owns 1,276 shares in the company, valued at $176,879.12. This trade represents a 49.49% decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Also, CEO Todd P. Kelsey sold 2,000 shares of the firm’s stock in a transaction on Wednesday, February 19th. The stock was sold at an average price of $140.00, for a total value of $280,000.00. Following the transaction, the chief executive officer now owns 87,665 shares in the company, valued at approximately $12,273,100. This trade represents a 2.23% decrease in their position. The disclosure for this sale can be found here. Over the last quarter, insiders have sold 4,137 shares of company stock worth $577,916. Company insiders own 1.76% of the company’s stock.
Plexus Company Profile
Plexus Corp. provides electronic manufacturing services in the United States and internationally. It offers design, develop, supply chain, new product introduction, and manufacturing solutions, as well as sustaining services to companies in the healthcare/life sciences, industrial/commercial, aerospace/defense, and communications market sectors.
Recommended Stories
- Five stocks we like better than Plexus
- How to Calculate Stock Profit
- NVIDIA Stock Surges on Bullish News: How High Could It Climb?
- Large Cap Stock Definition and How to Invest
- Why Boeing May Be Ready to Take Off After Latest Developments
- How Can Investors Benefit From After-Hours Trading
- eBay Nears Big Breakout: Time to Buy the Under-the-Radar Winner?
Receive News & Ratings for Plexus Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Plexus and related companies with MarketBeat.com's FREE daily email newsletter.